Taro Pharmaceutical
TARO
$42.20
Share price
-0.07%
Change (1 day)
65.10%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Net assets
Net assets on the balance sheet as of December 2023 : $1.77 B
According to Taro Pharmaceutical's latest financial reports the company has $1.77 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Taro Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $1.73 B | 1.13% |
| 2022-03-31 | $1.71 B | 0.94% |
| 2021-03-31 | $1.69 B | -19.64% |
| 2020-03-31 | $2.10 B | 10.39% |
| 2019-03-31 | $1.91 B | -13.54% |
| 2018-03-31 | $2.21 B | 6.59% |
| 2017-03-31 | $2.07 B | 7.05% |
| 2016-03-31 | $1.93 B | 36.67% |
| 2015-03-31 | $1.41 B | 38.88% |
| 2014-03-31 | $1.02 B | 14.55% |
| 2013-03-31 | $0.89 B | |
| 2011-12-31 | $0.57 B | 48.52% |
| 2010-12-31 | $0.38 B | 30.04% |
| 2009-12-31 | $0.29 B | 80.06% |
| 2008-12-31 | $0.16 B | 7.16% |
| 2007-12-31 | $0.15 B | 207.81% |
| 2006-12-31 | $49.78 M | -61.13% |
| 2005-12-31 | $0.12 B | -65.28% |
| 2004-12-31 | $0.36 B | 5.64% |
| 2003-12-31 | $0.34 B | 29.16% |
| 2002-12-31 | $0.27 B | 23.34% |
| 2001-12-31 | $0.21 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 3,765.68% | 🇺🇸 USA |
 Novartis NVS | $46.75 B | 2,527.75% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 4,918.75% | 🇺🇸 USA |
 Merck MRK | $37.63 B | 2,015.41% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 815.52% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 356.75% | 🇮🇱 Israel |